New study validates insulin nasal spray to deliver Alzheimer’s drug directly to the brain

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer’s disease treatments: Intranasal insulin, delivered via a simple nasal spray, safely and effectively reaches key memory regions of the brain in older adults. The study also revealed that people with early cognitive decline absorb it differently.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup